Dofetilide

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C19H27N3O5S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) R4Z9X1N2ND, chemically known as uk 68,798 but more generally known as dofetilide, which bears US NIH Compound Identifier 71329. European Medicines Agency schedules Dofetilide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06351MIG. The term DOFETILIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 5, No. 3 1991, List 31). World Health Organization schedules dofetilide in its Anatomical Therapeutic Chemical (ATC) Classification. DOFETILIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule dofetilide under HS 29350090 and SITC 51580. As of Q4 2014, DOFETILIDE remains US FDA's Preferred Term for this commodity. Dofetilide bears US NLM identifiers UMLS ID C0114771 and NCI Concept Code C47499. SMILES: S(=O)(=O)(NC1CCC(CCN(CCOC2CCC(NS(=O)(=O)C)CC2)C)CC1)C.